Blog

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you're an income investor, your primary focus is

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. However, when you're an income investor, your

All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But for income investors, generating consistent cash flow from

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you're an income investor, your primary focus is

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But when you're an income investor, your

All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But when you're an income investor, your primary focus is

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. However, when you're an income investor, your primary focus is

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. However, when you're an income investor, your

GSK plc GSK announced that the European Commission has approved its blockbuster respiratory drug, Nucala (mepolizumab), for treating certain patients with chronic obstructive pulmonary disease

Maximus MMS reported mixed first-quarter fiscal 2026 results, as earnings beat the Zacks Consensus Estimate while revenues missed the same.

MMS’s earnings per share of $1.85 beat the consensus mark

Antiviral pioneer Gilead Sciences is expected to report fourth-quarter earnings results on Tuesday after the closing bell. A Zacks Rank #3 (Hold) stock, Gilead surpassed earnings estimates in three

OneMain Holdings’ OMF fourth-quarter 2025 adjusted earnings of $1.59 per share surpassed the Zacks Consensus Estimate of $1.55. Moreover, the bottom line increased 37.1% from the year-ago

Investors with an interest in Retail - Restaurants stocks have likely encountered both Compass Group PLC (CMPGY) and Dutch Bros (BROS). But which of these two stocks offers value investors a better

Investors interested in Utility - Electric Power stocks are likely familiar with Portland General Electric (POR) and E.ON SE (EONGY). But which of these two stocks offers value investors a better

Investors looking for stocks in the Financial - Miscellaneous Services sector might want to consider either Grupo Financiero Banorte SAB de CV (GBOOY) or American Express (AXP). But which of these

Investors interested in Automotive - Domestic stocks are likely familiar with Blue Bird (BLBD) and Tesla (TSLA). But which of these two companies is the best option for those looking for undervalued

Investors looking for stocks in the Financial - Investment Management sector might want to consider either Federated Hermes (FHI) or Cohen & Steers Inc (CNS). But which of these two stocks presents

Investors interested in Banks - Foreign stocks are likely familiar with Shinhan Financial (SHG) and Erste Group Bank AG (EBKDY). But which of these two companies is the best option for those looking

Shares of Star Group, L.P. Common Unit SGU have gained 5.7% since reporting results for the first quarter of fiscal 2026. This compares with the S&P 500 index’s 3.8% decline over the same time

Pagaya Technologies’ PGY business fundamentally revolves around artificial intelligence (AI)-powered decisioning and underwriting, which helps partners (banks and fintech originators) approve and

Shares of Key Tronic Corporation KTCC have risen 2% since reporting results for the second quarter of fiscal 2026. This compares with the S&P 500 index’s 3.8% decline over the same time frame. Over

Fiserv, Inc. FISV is scheduled to release fourth-quarter 2025 results on Feb. 10, before market open.

FISV has outpaced the Zacks Consensus Estimate in three of the trailing four quarters and missed

WEX Inc. WEX reported better-than-expected fourth-quarter 2025 results, with both earnings and revenues beating the Zacks Consensus Estimate. However, the positive results did not affect the market

The Coca-Cola Company KO is slated to report fourth-quarter 2025 earnings on Feb. 10, before the opening bell. The company is expected to register year-over-year top and bottom-line growth when it

Spectrum Brands Holdings Inc. SPB reported strong first-quarter fiscal 2026 results, wherein the top and bottom lines beat the Zacks Consensus Estimate. Earnings improved year over year, while sales